0001493152-23-012905.txt : 20230419 0001493152-23-012905.hdr.sgml : 20230419 20230419160515 ACCESSION NUMBER: 0001493152-23-012905 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230419 DATE AS OF CHANGE: 20230419 EFFECTIVENESS DATE: 20230419 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Enveric Biosciences, Inc. CENTRAL INDEX KEY: 0000890821 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 954484725 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-455082 FILM NUMBER: 23830074 BUSINESS ADDRESS: STREET 1: 4851 TAMIAMI TRAIL N, SUITE 200 CITY: NAPLES STATE: FL ZIP: 34103 BUSINESS PHONE: 239-302-1707 MAIL ADDRESS: STREET 1: 4851 TAMIAMI TRAIL N, SUITE 200 CITY: NAPLES STATE: FL ZIP: 34103 FORMER COMPANY: FORMER CONFORMED NAME: AMERI Holdings, Inc. DATE OF NAME CHANGE: 20150527 FORMER COMPANY: FORMER CONFORMED NAME: SPATIALIZER AUDIO LABORATORIES INC DATE OF NAME CHANGE: 19950323 D/A 1 primary_doc.xml X0708 D/A LIVE 0000890821 Enveric Biosciences, Inc. 4851 TAMIAMI TRAIL N SUITE 200 NAPLES FL FLORIDA 34103 239-302-1707 DELAWARE None AMERI Holdings, Inc. SPATIALIZER AUDIO LABORATORIES INC Corporation true Joseph Tucker 4851 Tamiami Trail N Suite 200 Naples FL FLORIDA 34103 Executive Officer Director Chief Executive Officer and Director Kevin Coveney 4851 Tamiami Trail N Suite 200 Naples FL FLORIDA 34103 Executive Officer Chief Financial Officer Avani Kanubaddi 4851 Tamiami Trail N Suite 200 Naples FL FLORIDA 34103 Executive Officer President and Chief Operating Officer George Kegler 4851 Tamiami Trail N Suite 200 Naples FL FLORIDA 34103 Director Bob Dagher 4851 Tamiami Trail N Suite 200 Naples FL FLORIDA 34103 Executive Officer Chief Medical Officer Peter Facchini 4851 Tamiami Trail N Suite 200 Naples FL FLORIDA 34103 Executive Officer Chief Innovation Officer Douglas Lind 4851 Tamiami Trail N Suite 200 Naples FL FLORIDA 34103 Director Marcus Schabacker 4851 Tamiami Trail N Suite 200 Naples FL FLORIDA 34103 Director Frank Pasqualone 4851 Tamiami Trail N Suite 200 Naples FL FLORIDA 34103 Director Bevin O'Neil 4851 Tamiami Trail N Suite 200 Naples FL FLORIDA 34103 Director Michael D. Webb 4851 Tamiami Trail N Suite 200 Naples FL FLORIDA 34103 Director Pharmaceuticals Decline to Disclose 06b true 0000890821-22-000001 2022-07-22 false true true true false 0 H.C. Wainwright & Co., LLC 375 None None 430 PARK AVENUE 3RD FLOOR NEW YORK NY NEW YORK 10022 FL FLORIDA NY NEW YORK false 12780000 12780000 0 Includes aggregate exercise price of preferred investment options of $7,780,000 that may be received upon exercise such warrants. false 2 560000 0 Reflects fee of 7% from private offering and concurrent RD proceeds. Excludes $80,000 management fee, $135,000 of reimbursable expenses and PA warrants to purchase up to 70,000 shares, strike price of $10.00/share under Section 4(a)(2). 0 false Enveric Biosciences, Inc. /s/ Kevin Coveney Kevin Coveney Chief Financial Officer 2023-04-19